144 related articles for article (PubMed ID: 4827381)
1. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
Lillie MA; Mink IB
Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
[TBL] [Abstract][Full Text] [Related]
2. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
[TBL] [Abstract][Full Text] [Related]
3. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
Gjonnaess H; Fagerhol MK
Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
[TBL] [Abstract][Full Text] [Related]
4. Progestational agents and blood coagulation. VII. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study.
Ambrus JL; Mink IB; Courey NG; Niswander K; Moore RH; Ambrus CM; Lillie MA
Am J Obstet Gynecol; 1976 Aug; 125(8):1057-62. PubMed ID: 133615
[TBL] [Abstract][Full Text] [Related]
5. Progestational agents and blood coagulation. II.
Ambrus JL; Niswander KR; Courey NG; Wamsteker EF; Mink IB
Am J Obstet Gynecol; 1969 Apr; 103(7):994-1001. PubMed ID: 5774681
[No Abstract] [Full Text] [Related]
6. [The effect of oral contraceptives on levels of thyroid hormone, blood coagulation and ceruloplasmin (author's transl)].
Schenk H; Haralambus I; Leb G; Pickel H; Goebel R
MMW Munch Med Wochenschr; 1977 Jul; 119(28):941-4. PubMed ID: 70746
[TBL] [Abstract][Full Text] [Related]
7. [Coagulations studies in pregnancy and in treatment with gestagens].
Kullander S; Nilsson IM
Lakartidningen; 1966 Nov; 63(46):4381-91. PubMed ID: 5979939
[No Abstract] [Full Text] [Related]
8. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
Sabra A; Bonnar J
J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
[TBL] [Abstract][Full Text] [Related]
10. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
11. Coagulation studies of menopausal women taking estrogen replacement.
Beller FK; Nachtigall L; Rosenberg M
Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
[No Abstract] [Full Text] [Related]
12. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation and fibrinolytic enzyme studies during cyclic and continuous application of progestational agents.
Beller FK; Porges RF
Am J Obstet Gynecol; 1967 Feb; 97(4):448-59. PubMed ID: 4224893
[No Abstract] [Full Text] [Related]
14. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
Orlandi F; Cattaneo C; Gabasio S; Spandre M; Paccotti P; Rustichelli S
Arch Sci Med (Torino); 1978; 135(4):609-17. PubMed ID: 756722
[TBL] [Abstract][Full Text] [Related]
15. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
Medhat IA; Toppozada HK; Rizk MA; Khowessah MM; Malek AT; Moghazi M
Contraception; 1974 Apr; 9(4):379-92. PubMed ID: 4442281
[No Abstract] [Full Text] [Related]
16. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
Hedlin AM
Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral contraceptives on vitamin B6 nutriture of young women.
Vir SC; Love AH
Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
[TBL] [Abstract][Full Text] [Related]
18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary results of comparative trials of oral contraceptives].
Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
